"The U.S. Food and Drug Administration today approved Anoro Ellipta (umeclidinium and vilanterol inhalation powder) for the once-daily, long-term maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease ("...
- Clinician Information:
Arcapta Neohaler Patient Information including How Should I Take
In this Article
- What is indacaterol (Arcapta Neohaler)?
- What are the possible side effects of indacaterol (Arcapta Neohaler)?
- What is the most important information I should know about indacaterol (Arcapta Neohaler)?
- What should I discuss with my healthcare provider before taking indacaterol (Arcapta Neohaler)?
- How should I take indacaterol (Arcapta Neohaler)?
- What happens if I miss a dose (Arcapta Neohaler)?
- What happens if I overdose (Arcapta Neohaler)?
- What should I avoid while taking indacaterol (Arcapta Neohaler)?
- What other drugs will affect indacaterol (Arcapta Neohaler)?
- Where can I get more information?
What should I discuss with my healthcare provider before taking indacaterol (Arcapta Neohaler)?
You should not use this medication if you are allergic to indacaterol or any food products, or if you have asthma.
Indacaterol may contain lactose. Before taking this medication, tell your doctor if you have a hereditary form of galactose intolerance, severe lactase deficiency, or glucose galactose malabsorption.
To make sure you can safely use indacaterol, tell your doctor if you have any of these other conditions:
- heart disease, high blood pressure, coronary artery disease;
- a heart rhythm disorder;
- a seizure disorder such as epilepsy;
- diabetes; or
- a thyroid disorder.
FDA pregnancy category C. It is not known whether indacaterol will harm an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant while using this medication.
Do not give this medication to anyone under 18 years old without medical advice.
It is not known whether indacaterol passes into breast milk or if it could harm a nursing baby. Do not use this medication without telling your doctor if you are breast-feeding a baby.
How should I take indacaterol (Arcapta Neohaler)?
Use exactly as prescribed by your doctor. Do not use in larger or smaller amounts or for longer than recommended. Follow the directions on your prescription label.
This medication may increase the risk of asthma-related death. It is critical that you use only the prescribed dose of this medicine and follow all patient instructions for safe use of the medication.
Indacaterol is usually given once per day. Use the medicine at the same time each day. Follow your doctor's dosing instructions very carefully.
Arcapta Neohaler is a powder form of indacaterol that comes with a special inhaler device and blister packs containing capsules of the medicine. You will load one capsule into the inhaler device each time you use the medicine. Pushing the buttons on the side of the Neohaler device will pierce the capsule and release the medicine into the inhaler chamber.
This medication comes with patient instructions for safe and effective use. Follow these directions carefully. Ask your doctor or pharmacist if you have any questions.
You may have a mild cough for about 15 seconds after using the inhaler.
Do not stop using indacaterol without your doctor's advice. Your asthma symptoms may get worse after you stop using the medication.
Use indacaterol regularly to get the most benefit. Get your prescription refilled before you run out of medicine completely.
To be sure this medication is helping your condition and not causing harmful effects, your lung function will need to be tested often. You may also need blood tests at your doctor's office. Visit your doctor regularly.
Call your doctor right away if your symptoms do not improve, or if they get worse while using indacaterol. Tell your doctor if any of your medications do not seem to work as well in preventing attacks.
Store at room temperature away from moisture, heat, and light.
Do not try to wash or take apart the Neohaler device. You may use a tissue to wipe the mouthpiece after each use. Throw away the device when your capsules run out. Always use the inhaler device that comes with each new prescription.
Additional Arcapta Neohaler Information
- Arcapta Neohaler Drug Interactions Center: indacaterol inhl
- Arcapta Neohaler Side Effects Center
- Arcapta Neohaler FDA Approved Prescribing Information including Dosage
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.